Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-30

Clinical Trial Update: Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the safety and efficacy of the Brimonidine tartrate/timolol maleate fixed-dose combination in patients with glaucoma or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brimonidine tartrate/timolol maleate fixed-dose combination (Brimonidine tartrate; Timolol maleate)

Snippet

Sponsor: Allergan | Conditions: Ocular Hypertension | Phase 3 | Status: COMPLETED